Effectiveness and safety of mirikizumab in multirefractory ulcerative colitis: analysis from a real-world cohort
Digestive and Liver Disease · 2026-09 · 58 (9) · 1165-1172
DOI: 10.1016/j.dld.2026.06.007 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Digestive and Liver Disease, 2026-09. Verfasst von Laura Melotti und 9 weiteren Autor:innen. Beteiligte Einrichtung: IBD Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Electronic address: laura.melotti@aosp.bo.it. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IBD Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Electronic address: laura.melotti@aosp.bo.it.
- Department of Medical and Surgical and Sciences, University of Bologna, Bologna, Italy.
- Università di Pisa, U.O. Gastroenterologia Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
- Department of Medicine,Western University, Ontario, Canada; Department of Epidemiology and Biostatistics,Western University, Ontario, Canada.
- Division of Gastroenterology, Western University, London, Ontario, Canada.
- IBD Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Zitieren
APA
Melotti, L., Monicelli, O., Dussias, N. K., Pardi, V., Jairath, V., Hupé, M., Salice, M., Privitera Hrustemovic, H., Gionchetti, P., & Rizzello, F. (2026). Effectiveness and safety of mirikizumab in multirefractory ulcerative colitis: analysis from a real-world cohort. Digestive and Liver Disease, 58(9), 1165-1172. https://doi.org/10.1016/j.dld.2026.06.007
Vancouver
Melotti L, Monicelli O, Dussias NK, Pardi V, Jairath V, Hupé M, et al. Effectiveness and safety of mirikizumab in multirefractory ulcerative colitis: analysis from a real-world cohort. Digestive and Liver Disease. 2026;58(9):1165-1172. doi:10.1016/j.dld.2026.06.007
BibTeX
@article{Melotti2026,
author = {Melotti, Laura and Monicelli, Ottavia and Dussias, Nikolas Konstantine and Pardi, Veronica and Jairath, Vipul and Hupé, Marianne and Salice, Marco and Privitera Hrustemovic, Hana and Gionchetti, Paolo and Rizzello, Fernando},
title = {Effectiveness and safety of mirikizumab in multirefractory ulcerative colitis: analysis from a real-world cohort},
journal = {Digestive and Liver Disease},
year = {2026},
volume = {58},
number = {9},
pages = {1165--1172},
doi = {10.1016/j.dld.2026.06.007}
}
EUVIMED